A Proton Pump Inhibitor’s Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized Study

키워드

참고문헌 (32)

1. 신재무, "Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors", Journal of Neurogastroenterology and Motility (JNM), 19(1), pp.25~35 (2013), 대한소화기 기능성질환∙운동학회
2. Targownik LE, "Use of proton pump inhibitors and risk of osteoporosis-related fractures", CMAJ, 179, pp.319~326 (2008)
3. Yang YX, "Long-term proton pump inhibitor therapy and risk of hip fracture", JAMA, 296, pp.2006~2296 (2006)
4. Yu EW, "Acid-suppressive medications and risk of bone loss and fracture in older adults", Calcif Tissue Int, 83, pp.251~259 (2008)
5. Targownik LE, "Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss", Gastroenterology, 138, pp.896~904 (2010)
6. Kaye JA, "Proton pump inhibitor use and risk of hip fractures in patients without major risk factors", Pharmacotherapy, 28, pp.951~959 (2008)
7. Chonan O, "Effect of L-lactic acid on calcium absorption in rats fed omeprazole", J Nutr Sci Vitaminol, 44, pp.473~481 (1998)
8. Hardy P, "Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis", Artif Organs, 22, pp.569~573 (1998)
9. O’Connell MB, "Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial", Am J Med, 118, pp.778~781 (2005)
10. Serfaty-Lacrosniere C, "Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans", J Am Coll Nutr, 14, pp.364~368 (1995)
11. Mizunashi K, "Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans", Calcif Tissue Int, 53, pp.21~25 (1993)
12. Hansen KE, "Do proton pump inhibitors decrease calcium absorption?", J Bone Miner Res, 25, pp.2786~2795 (2010)
13. Kocher MS, "Osteopetrosis", Am J Orthop, 32, pp.222~228 (2003)
14. Dhonukshe-Rutten RA, "Vitamin B-12 status is associated with bone mineral content and bone mineral density in frail elderly women but not in men", J Nutr, 133, pp.801~807 (2003)
15. Lubec B, "Evidence for McKusick’s hypothesis of deficient collagen cross-linking in patients with homocystinuria", Biochim Biophys Acta, 1315, pp.159~162 (1996)
16. McLean RR, "Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women", J Clin Endocrinol Metab, 93, pp.2206~2212 (2008)
17. McLean RR, "Homocysteine as a predictive factor for hip fracture in older persons", N Engl J Med, 350, pp.2042~2049 (2004)
18. Gagnemo-Persson R, "Growth of the parathyroid glands in omeprazole-treated chickens", Scand J Gastroenterol, 29, pp.493~497 (1994)
19. Gagnemo-Persson R, "Chicken parathyroid hormone gene expression in response to gastrin, omeprazole, ergocalciferol, and restricted food intake", Calcif Tissue Int, 61, pp.210~215 (1997)
20. Kim HK, "Clinical trial: inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects", J Gastroenterol Hepatol, 25, pp.1618~1625 (2010)
21. Li H, "The transport of a reversible proton pump antagonist, 5, 6-dimethyl-2-(4-Fluorophenylamino)-4-(1-methyl-1,2,3, 4-tetrahydroisoquinoline-2-yl) pyrimidine hydrochloride (YH1885), across caco-2 cell monolayers", Drug Metab Dispos, 29, pp.54~59 (2001)
22. pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease, "J Pharmacol Exp Ther", 2009, 671~679
23. 김용길, "A Matched Case-Control Study of a Novel Acid-Pump Antagonist and Proton-Pump Inhibitor for the Treatment of Iatrogenic Ulcers Caused by Endoscopic Submucosal Dissection", Gut and Liver, 4(1), pp.25~30 (2010), 거트앤리버 발행위원회
24. Dixon MF, "Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994", Am J Surg Pathol, 20, pp.1161~1181 (1996)
25. Fossmark R, "Decreased bone mineral density and reduced bone quality in H(+)", K(+) ATPase beta-subunit deficient mice, 2012, pp.113, 141~147
26. Joo MK, "The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats", Mol Med Rep, 7, pp.1267~1272 (2013)
27. Kocsis I, "Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children", Calcif Tissue Int, 71, pp.129~132 (2002)
28. Sharara AI, "Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: a prospective matched controlled study", Metabolism, 62, pp.518~526 (2013)
29. Roux C, "Increase in vertebral fracture risk in postmenopausal women using omeprazole", Calcif Tissue Int, 84, pp.13~19 (2009)
30. Bo-Linn GW, "An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium", J Clin Invest, 73, pp.640~647 (1984)
31. Nam YD, "Comparative analysis of Korean human gut microbiota by barcoded pyrosequencing", PLoS One, 6, pp.e22109~ (2011)
32. Wright MJ, "Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial", J Bone Miner Res, 25, pp.2205~2211 (2010)

관련 논문AI추천